首页> 外文期刊>Cellular Physiology and Biochemistry >Effect of the Total Extract of Averrhoacarambola (Oxalidaceae) Root on the Expression Levels of TLR4 and NF-κB in Streptozotocin-Induced Diabetic Mice
【24h】

Effect of the Total Extract of Averrhoacarambola (Oxalidaceae) Root on the Expression Levels of TLR4 and NF-κB in Streptozotocin-Induced Diabetic Mice

机译:杨桃根总提取物对链脲佐菌素诱导的糖尿病小鼠TLR4和NF-κB表达水平的影响

获取原文
           

摘要

Background: Averrhoacarambola L., which is a folk medicine used in diabetes mellitus (DM) in ancient China, has been reported to have anti-diabetic efficacy. Aims: The aim of this study was to evaluate the hypoglycemic effect of the extract of Averrhoacarambola L. root (EACR) on the regulation of the Toll-like receptor 4 (TLR4)-Nuclear-factor kappa B (NF-κB) pathway in B) pathway in streptozotocin (STZ)-induced diabetic mice. Methods: the mice were injected with STZ (120 mg/kg body weight) via a tail vein. After 72 h, the mice with FBG ≥ 11.1 mmol/L were confirmed as having diabetes. Subsequently, the mice were treated intragastrically with EACR (300, 600, 1200 mg/kg body weight/d) and metformin (320 mg/kg body weight/d) for 14 days. Results: As a result the serum fasting blood glucose (FBG), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were decreased following EACR administration. Immunohistochemical analysis revealed that the pancreatic tissue expression levels of TLR4 and NF-κB were downregulated after EACR administration. EACR suppressed pancreatic mRNA expression level of TLR4 and blocked the downstream NF-κB pathway in the pancreas. According to Western blot analysis EACR suppressed pancreatic TLR4 and NF-κB protein expression levels. Histopathological examination of the pancreas showed that STZ-induced pancreas lesions were alleviated by the EACR treatment. Conclusion: These findings suggest that the modulation of the IL-6 and TNF-α inflammatory cytokines and the suppression of the TLR4-NF-κB pathway are most likely involved in the anti-hyperglycemic effect of EACR in STZ-induced diabetic mice.
机译:背景:据报道,在中国古代用于糖尿病(DM)的民间药物Averrhoacarambola L.具有抗糖尿病功效。目的:本研究旨在评估大叶杨提取物(EACR)对Toll样受体4(TLR4)-核因子κB(NF-κB)途径的调节的降血糖作用。 B)链脲佐菌素(STZ)诱导的糖尿病小鼠中的途径。方法:通过尾静脉给小鼠注射STZ(120 mg / kg体重)。 72小时后,FBG≥11.1 mmol / L的小鼠被确认患有糖尿病。随后,用EACR(300、600、1200 mg / kg体重/ d)和二甲双胍(320 mg / kg体重/ d)胃内治疗小鼠14天。结果:结果,EACR给药后血清空腹血糖(FBG),白介素6(IL-6)和肿瘤坏死因子-α(TNF-α)水平降低。免疫组织化学分析显示,EACR给药后,胰腺组织中TLR4和NF-κB的表达水平下调。 EACR抑制胰腺TLR4的mRNA表达水平,并阻断胰腺下游的NF-κB通路。根据蛋白质印迹分析,EACR抑制胰腺TLR4和NF-κB蛋白表达水平。胰腺的组织病理学检查显示,EACR治疗可减轻STZ诱导的胰腺病变。结论:这些发现表明,STZ诱导的糖尿病小鼠中,IL-6和TNF-α炎性细胞因子的调节以及TLR4-NF-κB途径的抑制很可能与EACR的降血糖作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号